1. N-methyl-D-aspartate glutamate receptor blockade attenuates lung injury associated with experimental sepsis.
- Author
-
da Cunha AA, Pauli V, Saciura VC, Pires MG, Constantino LC, de Souza B, Petronilho F, Rodrigues de Oliveira J, Ritter C, Romão PR, Boeck CR, Roesler R, Quevedo J, and Dal-Pizzol F
- Subjects
- Animals, Disease Models, Animal, Dizocilpine Maleate administration & dosage, Dose-Response Relationship, Drug, Excitatory Amino Acid Antagonists administration & dosage, Lung Injury etiology, Lung Injury metabolism, Male, Oxidative Stress drug effects, Rats, Rats, Wistar, Treatment Outcome, Dizocilpine Maleate therapeutic use, Excitatory Amino Acid Antagonists therapeutic use, Lung Injury drug therapy, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors, Sepsis complications
- Abstract
Background: The aim of this study was to examine the effects of the N-methyl-D-aspartate receptor (NMDAR) channel blocker dizocilpine (MK-801) on lung injury in rats submitted to experimental sepsis induced by cecal ligation and perforation (CLP)., Methods: Adult male Wistar rats submitted to CLP were given a single systemic injection of MK-801 (subcutaneously at 0.3 mg/kg) administered 4 or 7 h after CLP induction. Twelve hours after CLP BAL was performed to determine total cell count, protein content, and inflammatory parameters. In addition, lung was excised for histopathologic analyses and determination of NMDAR subunits content. In a separate cohort of animals mortality was recorded for 5 days., Results: Animals submitted to sepsis induced by CLP showed an increase in the content of NMDAR subunits NR1 and NR2A in the lung. Administration of MK-801 4 h after CLP induction resulted in a decrease in BAL fluid cellular content and decreased levels of proinflammatory cytokines. In addition, MK-801 decreased lung oxidative stress markers and histopathologic alterations and improved survival., Conclusions: These findings indicate that NMDAR blockade might represent a promising novel therapeutic strategy for the treatment of sepsis and inflammatory disorders.
- Published
- 2010
- Full Text
- View/download PDF